Hints and tips:
Related Special Reports
...Japan’s Eisai and Eli Lilly of the US are now making progress against Alzheimer’s disease. An entirely new class of dementia drugs could result, we wrote....
...Just a couple of weeks ago, Eli Lilly released this kind of blockbuster drug that was shown to slow the development of Alzheimer’s....
...Shares in Regeneron rose more than 7 per cent on Monday after Mr Trump’s doctors revealed over the weekend that he had been given the drug, as investors hoped this was a sign it was heading for an emergency...
...Shares of Regeneron and Eli Lilly rose after Mr Trump’s endorsement. Each company could rake in about $1.5bn next year from sales of the antibodies, estimates Bernstein....
...Mr Trump took Regeneron’s treatment when he was suffering from the disease....
...Mr Trump’s comments sent shares in Regeneron up more than 3 per cent in after-hours trading, while those in Eli Lilly rose 1 per cent....
...He added that his broad industry experience — including time at Eli Lilly and medical technology company Baxter — would help him “challenge internal thinking”....
...Richard Waters: Tech sector looks beyond WFH The outlook for 2021 will be in focus when pharmaceutical groups such as Johnson & Johnson, Abbott Laboratories and Eli Lilly report....
...Some big shareholders want Mr Taurel, the former chief executive of US drugmaker Eli Lilly who has been chair since 2016, to set a departure date before Pearson’s annual general meeting next year, to avoid...
...David Ricks, chief executive of Eli Lilly, which is developing an antibody treatment for Covid-19, said last month he expected long-term demand for the drug, predicting that not everyone would be vaccinated...
...Stocks were also hit by news that drug companies Johnson & Johnson and Eli Lilly were halting trials of an experimental Covid-19 vaccine and therapy, respectively, because of safety concerns....
...Mr Hui said the latest plan was likely to advocate for greater self-reliance in essential technologies, including semiconductor development....
...Lower turnout among black voters in 2016 contributed to Mr Trump’s victory, said Lilly Goren, a political-science professor at Carroll University in Wisconsin....
...Regeneron’s rival Eli Lilly is producing a similar treatment, which it is able to manufacture more quickly since it derived its antibodies from a single source....
...He told the Financial Times last week that, despite the surges, he had not briefed Mr Trump for two months....
...The group sold 300 tickets in the first 24 hours of opening its reservation system — “10 days out which is a long time out for cinema for films that are at least six months old”, Mr Lilly said....
...In surveys conducted since last week’s presidential debate and Mr Trump’s admission to hospital, Mr Biden’s lead has been growing, especially with independents, as the president doubles down on his attempt...
...“EIB is actively supporting identified market failures with innovative financial instruments,” said Mr Hoyer. “Antimicrobial resistance is clearly one.”...
...Eli Lilly’s antibody treatment reduced hospitalisations....
...“Science is global,” Mr Sun says. “It shouldn’t be about nations.”...
...Scholar Norman Ornstein says Mr Trump’s recklessness has reached dangerous new heights....
...Mr Bancel joined drugmaker Eli Lilly in a role overseeing manufacturing after business school as most of his classmates were going to tech start-ups....
...The Forty Seven acquisition is Mr O’Day’s second major deal since taking the helm two years ago....
...The issue of testing infrastructure and lab capacity may need to be rethought, said Mr Schwan of Roche....
...Yet the risk, with so much retail space opening up, is a “massive cannibalisation” of the market, said Mr Rose. Mr Lilly insists that Everyman is set apart by the experience it offers....
International Edition